QL1604
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for QL1604, covering 2020-06-17 to 2025-02-11. Get the full timeline:
Most recent: Clinical Trial Update: a Study of QL1706 or QL1604 in Patients With Limited-stage Small Cell Lung Cancer After Chemoradiotherapy. [Phase 3]